# Porton Advanced Solution

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/porton-advanced-solution

- Industry: Pharmaceuticals
- Headquarters: Jiangsu, China
- Website: www.portonadvanced.com
- Total disclosed funding: $80M
- Latest round: Series B (Aug 21, 2022)
- Investors on record: 11

## About

Based in Jiangsu, China, and founded in 2018, Porton Advanced Solution Ltd., a.k.a. Porton Advanced is a subsidiary of Porton Pharma Solutions, providing process development (PD), analytical development (AD), GMP manufacturing, and testing services to meet the therapeutic product needs at pre-clinical, clinical, and commercial stages of the clients. In August 2022, Porton Advanced Solution Ltd. raised USD 80 million in a Series B funding led by China Merchants Group Limited, with participation from China Merchants Capital, China Merchants Securities, Chongqing Porton Fine Chemicals Co., Ltd., CS Capital, Fosun Health Capital, Gortune Investment, HM Capital, Momentum Venture Capital, Ruilian Investment, and SDICTK.

The company provides technology transfer, analytical development, process development, testing services, cGMP manufacturing, and discovery research, including proprietary technology licenses, across different cell and gene therapy segments. Porton Advanced also provides plasmid development and manufacturing services, including a chromatography purification process, a platform process for linearized plasmid production, an in-line continuous process of E.coli lysis, and a BIA two-step purification platform process, and more.

The company plans to use its proceeds from August 2022 funding to improve the development and manufacturing capacity in both China and overseas.

## Funding rounds

- Series B, Aug 21, 2022, $80M — China Merchants Group Limited, Chongqing Porton Fine Chemicals Co., Ltd., China Merchants Capital, China Merchants Securities, CS Capital, Gortune Investment, Momentum Venture Capital, HM Capital, Fosun Health Capital, SDICTK, Ruilian Investment

## Investors

- China Merchants Group Limited — Series B
- Chongqing Porton Fine Chemicals Co., Ltd. — Series B
- China Merchants Capital (https://capitalatlas.ai/funds/china-merchants-capital) — Series B
- China Merchants Securities — Series B
- CS Capital — Series B
- Gortune Investment (https://capitalatlas.ai/funds/gortune-investment) — Series B
- Momentum Venture Capital — Series B
- HM Capital (https://capitalatlas.ai/funds/hm-capital) — Series B
- Fosun Health Capital (https://capitalatlas.ai/funds/fosun-health-capital) — Series B
- SDICTK — Series B
- Ruilian Investment — Series B